Business intelligence
for the Lab Diagnostics industry
Already a Subscriber? Log in Here
We offer four monthly reports, each focused on the industry from a unique angle, covering science & technology, compliance, business, and legislation & regulations.
Diagnostic Testing & Emerging Technologies
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Lab Compliance Advisor
Offers practical, “what-to-do” and “how-to-do-it” help to comply with the latest state and federal laws, rules, and regulations that affect your diagnostic lab or pathology practice
Laboratory Industry Report
Keeps you up-to-date on lab business and competitive strategy, market trends and opportunities, and M&A and investment activity in today’s diagnostic lab industry
National Lab Reporter
Keeps you up-to-date on federal and state laws, regulations, new legislation, and court cases that affect your diagnostic lab or pathology practice
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
G2 Intelligence Has Some Exciting News to Share!
G2 Intelligence to change subscription model to better serve the laboratory industry with more analysis and insight
Is a Newly Proposed Rule Meant to Stop Healthcare Consolidation?
The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.
What Labs Need to Know About Proper Documentation for Billing
Billing and coding consultant Diana Voorhees shares her tips to ensure compliance when billing laboratory services.
Inside the Lab Industry: Q2 Earnings Decline Despite Rebound in Core Business
Though COVID-19 testing declines continue to negatively affect lab industry profits, the latest figures suggest the worst may be over.
Expert Q&A: Trends in Cybersecurity and How Labs Can Protect Themselves
Expert discusses the increasing number of attacks against the healthcare industry and how labs can protect their systems and data.
October 2023 Labs in Court
Recent cases involve charges and judgments related to COVID-19 add-on tests, genetic testing fraud, and kickbacks.
The Diagnostics Pipeline: Diagnostics Make Up One-Third of Total 2023 Recalls
With recent test recalls announced by Universal Medtech and QuidelOrtho, such products now make up one-third of 2023 total recalls listed by the FDA.
G2 Intelligence Has Some Exciting News to Share!
G2 Intelligence to change subscription model to better serve the laboratory industry with more analysis and insight
Lab Enforcement Trends and Avoiding Compliance Pitfalls
This session will focus on recent enforcement trends and provide actionable advice on how to avoid engaging in practices under government scrutiny and factors considered by the government under their detailed guidance.
What’s New in ‘24 for Laboratory Coding & Billing
This session will annual billing changes and critical developments currently facing laboratory medicine.
Disrupting Healthcare with Transparency and Dialog for Sustainable Success
This session will discuss the advantages of rethinking your revenue cycle workflow leveraging data automation to cost-effectively capture clean info for every test at order intake
What Does Congress Have in Store for Fixing PAMA?
This session will help laboratory owners understand the benefits of PAMA and how SALSA can improve it, and what actions Congress can take
Is a Newly Proposed Rule Meant to Stop Healthcare Consolidation?
The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.